Autoscope subsidiary CEO Chad Stelzig resigns; CFO Frank Hallowell named interim CEO

AUTOSCOPE TECHNOLOGIES CORP

Chad Stelzig resigned as President and CEO of Image Sensing Systems (ISNS), a wholly-owned subsidiary of Autoscope, effective Oct 1, 2021.
Frank Hallowell, current CFO of Autoscope and ISNS, appointed Interim CEO of ISNS.
Stelzig will assist in transition; board to begin search for permanent successor.
Chairman Andrew Berger thanked Stelzig for 10 years of service and accomplishments.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Chad A. Stelzig

President and Chief Executive Officer of Image Sensing Systems, Inc.

AATC · AUTOSCOPE TECHNOLOGIES CORP

Effective: 2021-10-01
Filed: October 7, 2021, 7:59 PM ET

On October 1, 2021, Chad A. Stelzig notified the Board of Directors of Autoscope Technologies Corporation (the "Company") that he was resigning as the President and Chief Executive Officer of Image S ensing Systems, Inc. (“ISNS”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chad A. Stelzig resigned as President and Chief Executive Officer of Image Sensing Systems, Inc. at AUTOSCOPE TECHNOLOGIES CORP.

Action: resigned
Role: President and Chief Executive Officer of Image Sensing Systems, Inc.

Exact text from the filing

On October 1, 2021, Chad A. Stelzig notified the Board of Directors of Autoscope Technologies Corporation (the "Company") that he was resigning as the President and Chief Executive Officer of Image S ensing Systems, Inc. (“ISNS”).

View on SEC.gov

AUTOSCOPE TECHNOLOGIES CORP filing history →

Source: SEC EDGAR

accession 0000897101-21-000810

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.